GYOEDU Resident: BRCA, Genetics and Parp Inhibitors
PARP Trials List
Open source article to read for reference
Shitanshu Uppal
Leadership Styles
As a new attending or a fellow supervising a team
GYOEDU Resident: Ovarian Cancer - Workup of a New Patient
GYOEDU Subscription FAQs
GYOEDU offers a tiered subscription system where each additional service
The Living Room
Originally featured in Publications Update # 77
Warning: This podcast episode
Keynote B21 - Pembrolizumab in High-Risk Endometrial Cancer (Video Explainer)
Video Explaining B-21 Trial
Keynote B-21: Pembrolizumab vs. Placebo in High-risk Endometrial Cancer
Adjuvant Pembrolizumab did not improve DFS in high-risk endometrial cancer population
HIPEC in ovarian cancer
Korean HIPEC trial - IDS patients only 2023
HIPEC combined with ICS significantly improved PFS and OS in advanced-stage ovarian cancer patients, without increasing the rate of severe postoperative complications. A notable reduction in peritoneal recurrence may contribute to the OS improvement.
Publications Update # 78
Medicine is Difficult article, discussion of interlace trial and PRIMA final survival data